ENIGMA Clinical High Risk for Psychosis Working Group, Haas SS, Ge R, Agartz I, Amminger GP, Andreassen OA, Bachman P, Baeza I, Choi S, Colibazzi T, Cropley VL, de la Fuente-Sandoval C, Ebdrup BH, Fortea A, Fusar-Poli P, Glenthøj BY, Glenthøj LB, Haut KM, Hayes RA, Heekeren K, Hooker CI, Hwang WJ, Jahanshad N, Kaess M, Kasai K et al. (2024)
Normative Modeling of Brain Morphometry in Clinical High Risk for Psychosis
JAMA Psychiatry, 81 (1), 77-88
DOI 10.1001/jamapsychiatry.2023.3850, PubMed 37819650

Igland J, Forster R, Jenum AK, Strandberg RB, Berg TJ, Røssberg JI, Iversen MM, Buhl ES (2024)
How valid is a prescription-based multimorbidity index (Rx-risk) in predicting mortality in the Outcomes and Multimorbidity In Type 2 diabetes (OMIT) study? A nation-wide registry-based cohort study from Norway
BMJ Open, 14 (3), e077027
DOI 10.1136/bmjopen-2023-077027, PubMed 38548358

Malkomsen A, Røssberg JI, Dammen T, Wilberg T, Løvgren A, Ulberg R, Evensen J (2024)
"It takes time to see the whole picture": patients' views on improvement in cognitive behavioral therapy and psychodynamic therapy after three years
Front Psychiatry, 15, 1342950
DOI 10.3389/fpsyt.2024.1342950, PubMed 38559399